SCHEMBL24328640

SCHEMBL24328640

c1ccc(-c2nc(-c3ccccc3)nc(-c3ccc4c(c3)C(c3ccccc3)(c3cnc5ccccc5c3)c3ccccc3-4)n2)cc1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP2 O95551 1/20 0.37
MAPT P10636 3/20 0.36
SMN1; SMN2 Q16637 3/20 0.36
MEN1 O00255 2/20 0.36
KMT2A Q03164 2/20 0.36
KDM4E B2RXH2 1/20 0.36
LMNA P02545 1/20 0.36
OPRK1 P41145 1/20 0.36
MGAM O43451 1/20 0.36
ITGA4 P13612 1/20 0.35
ITGB7 P26010 1/20 0.35
AKR1C3 P42330 1/20 0.35
AKR1C2 P52895 1/20 0.35
ALDH1A1 P00352 2/20 0.35
HPGD P15428 1/20 0.35
CYP2A6 P11509 1/20 0.35
PIK3CD O00329 2/20 0.34
PIK3CA P42336 2/20 0.34
PIK3CB P42338 1/20 0.34
MTOR P42345 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12133811 0.87 MEN1 (0.46) MAPTSMN1; SMN2MEN1KMT2AKDM4E
SCHEMBL12133795 0.87 MEN1 (0.46) MAPTSMN1; SMN2MEN1KMT2AKDM4E
SCHEMBL28610643 0.87 NPC1 (0.46) MAPTSMN1; SMN2MEN1KMT2AKDM4E
SCHEMBL31379859 0.87 NPC1 (0.46) MAPTSMN1; SMN2MEN1KMT2AKDM4E
SCHEMBL16772392 0.86 MEN1 (0.45) MAPTSMN1; SMN2MEN1KMT2AKDM4E
SCHEMBL17932286 0.86 MEN1 (0.45) MAPTSMN1; SMN2MEN1KMT2AKDM4E
SCHEMBL12133916 0.86 MEN1 (0.45) MAPTSMN1; SMN2MEN1KMT2AKDM4E
SCHEMBL18468628 0.86 MEN1 (0.45) MAPTSMN1; SMN2MEN1KMT2AKDM4E
SCHEMBL17932736 0.86 MEN1 (0.45) MAPTSMN1; SMN2MEN1KMT2AKDM4E
SCHEMBL17932672 0.86 MEN1 (0.45) MAPTSMN1; SMN2MEN1KMT2AKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11299466-B2 Compound, and organic electronic element comprising same LG CHEM, LTD. 2022-04-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11299466-B2 Compound, and organic electronic element comprising same OR10J3, ETV6, ODC1 TDP2 3634/4885MAPT 2593/4885SMN1; SMN2 2222/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.